Trial Profile
Linezolid overexposure as a haematological toxicity marker
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Sep 2015
Price :
$35
*
At a glance
- Drugs Linezolid (Primary)
- Indications Gram-positive infections
- Focus Adverse reactions
- 08 Sep 2015 New trial record